financetom
Business
financetom
/
Business
/
SPAR Group Q3 revenue up 28.2% on US, Canada growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SPAR Group Q3 revenue up 28.2% on US, Canada growth
Nov 14, 2025 5:31 AM

Overview

* SPAR Group Q3 rev up 28.2% yr/yr, driven by U.S. and Canada growth

* Company reports Q3 net loss of $8.8 mln, impacted by restructuring costs

* Adjusted EBITDA for Q3 declines to $90 thousand from $221 thousand last year

Outlook

* SPAR Group plans to focus on higher-margin merchandising services in 2026

* Company targets SG&A expenses at $6.5 mln per quarter or lower

* SPAR Group amended credit facilities to enhance financial flexibility

Result Drivers

* REVENUE GROWTH - Net revenues increased 28.2% yr/yr, driven by growth in U.S. and Canada

* REVENUE MIX IMPACT - Higher proportion of retailer remodeling work weighed on margins

* RESTRUCTURING COSTS - $4 mln restructuring costs incurred in Q3, impacting net loss

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $41.42

Revenue mln

Q3 EPS -$0.37

Q3 Net -$8.76

Income mln

Q3 Gross $7.69

Profit mln

Q3 -$5.92

Operatin mln

g Income

Q3 -$7.05

Pretax mln

Profit

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
3M, HD Hyundai Korea Shipbuilding & Marine Engineering to Partner on Research for Liquid Hydrogen Storage Tanks
3M, HD Hyundai Korea Shipbuilding & Marine Engineering to Partner on Research for Liquid Hydrogen Storage Tanks
Mar 7, 2024
01:20 PM EST, 03/07/2024 (MT Newswires) -- 3M ( MMM ) agreed with HD Hyundai Korea Shipbuilding & Marine Engineering on a joint research project to develop large liquid hydrogen storage tanks using the conglomerate's glass bubbles insulation system. This collaboration is a major step forward in the pursuit of making hydrogen technologies available at scale, 3M Advanced Materials Division...
Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
Mar 7, 2024
Thursday, Creative Medical Technology Holdings Inc ( CELZ ) secured FDA authorization for an expanded access therapy using CELZ-201, a cell-based program to manage abnormal glucose tolerance and prevent Type 1 diabetes (T1D) in high-risk individuals. The therapy uses CELZ-201 to potentially prevent T1D onset and is believed to be a first in medical history.  This personalized medicine approach focuses on a single...
Cellebrite Launches FedRAMP Authorization Process for SaaS Offerings
Cellebrite Launches FedRAMP Authorization Process for SaaS Offerings
Mar 7, 2024
01:20 PM EST, 03/07/2024 (MT Newswires) -- Cellebrite DI ( CLBT ) said Thursday it has launched the process to seek Federal Risk and Authorization Management Program, or FedRAMP, authorization for its software-as-a-service offerings. The company said it has enlisted cybersecurity firm Coalfire to assist in the activities required to complete the process within the next 12 months. FedRAMP authorization...
Marinus Pharmaceuticals Ztalmy Gains Approval From UK Medicines and Healthcare Products Regulatory Agency
Marinus Pharmaceuticals Ztalmy Gains Approval From UK Medicines and Healthcare Products Regulatory Agency
Mar 7, 2024
01:25 PM EST, 03/07/2024 (MT Newswires) -- Marinus Pharmaceuticals' ( MRNS ) Ztalmy was approved by the UK Medicines and Healthcare products Regulatory Agency on Thursday for the treatment of seizures in patients with cyclin-dependent kinase-like 5 deficiency disorder. Ztalmy, or ganaxolone, is the first anti-seizure medication approved for the treatment of this rare genetic disorder in the UK, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved